Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome - Wikidata - awgldk - TriplyDB

Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome

Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome

http://www.wikidata.org/entity/Q28266821

about

ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion.Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease A Bioinformatics Resource for TWEAK-Fn14 Signaling Pathway BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.TNF-like weak inducer of apoptosis (TWEAK) promotes beta cell neogenesis from pancreatic ductal epithelium in adult mice.Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo.Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2.Predictive gene signature of response to the anti-TweakR mAb PDL192 in patient-derived breast cancer xenografts Targeting Src family kinases inhibits bevacizumab-induced glioma cell invasion TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.Reciprocal activation of transcription factors underlies the dichotomy between proliferation and invasion of glioma cells.TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling.Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma.Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis Fn14•TRAIL effectively inhibits hepatocellular carcinoma growth.Chronic activation of FXR in transgenic mice caused perinatal toxicity and sensitized mice to cholesterol toxicity.Development of an Fn14 agonistic antibody as an anti-tumor agent.AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasis The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting.Fn14 receptor promotes invasive potential and metastatic capacity of non-small lung adenocarcinoma cells through the up-regulation of integrin α6 Rap1 GTPase Inhibits Tumor Necrosis Factor-α-Induced Choroidal Endothelial Migration via NADPH Oxidase- and NF-κB-Dependent Activation of Rac1.Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer.Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity Development and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cells.The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatment The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression.Diffuse glioma growth: a guerilla war The Src homology 3 domain-containing guanine nucleotide exchange factor is overexpressed in high-grade gliomas and promotes tumor necrosis factor-like weak inducer of apoptosis-fibroblast growth factor-inducible 14-induced cell migration and invasio Neural stem cells, inflammation and NF-kappaB: basic principle of maintenance and repair or origin of brain tumours?The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma.TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.

P2860

Q24623558-A732EEDB-2C4E-49FF-A199-01DED564D6B3 Q24655658-BE394A2D-762E-4E14-87F9-A4ABEFFA1F38 Q26795601-5B8ABD09-9116-4797-A324-AFEB650E7947 Q26999255-2BB8F331-09EB-4AC8-8319-E18AB13BCEF1 Q28729829-926C4FCD-AA97-43D6-9A59-1BEC4FB7B8B4 Q30724766-338B2D5D-AB48-48B5-9805-7E816553850E Q31132382-D538B2AA-DB7E-4CBE-89D9-2F14F7149C89 Q33566796-1ACF325D-9C11-43C8-B86E-4BF8949C0656 Q33676528-390710F0-143E-415A-AC9B-ED232FE6C078 Q34321677-E83190D1-378A-467A-ABB7-25CE87DE65A1 Q34465302-A2206C1D-1FEF-4292-9AC3-2DB33461999D Q34606869-CF7B4BC3-C0B3-4907-A0D0-423EB61CBD19 Q34764239-9D34E63E-7851-44B0-B649-ECA1381ACF5F Q34773994-A1BE7ACE-5FF7-44DB-BA3B-41077802BBF0 Q34785621-7284E15A-B69B-465F-979E-FD286B7CE322 Q34964906-448F3D9A-ACAE-46F9-9DD1-43177C560125 Q34974464-75A631EE-ABC5-4A50-8ADF-F6C15ACBFD17 Q34985441-DEA14DD5-5479-4692-B8FF-4AB5CD99D49F Q34993747-36B16925-D1F4-4532-847F-7F1C5FBB69A2 Q35018711-4B3B3CBA-DE49-42A4-856E-4C85C45349CD Q35441714-B56F10C3-0EB1-40CC-8F34-016DAFC0C5CD Q35556794-4D578E0C-CFCC-4A04-A3CB-D963B2742075 Q35600629-A4BD7663-F9CA-4B1B-B94C-F1A2B41D7657 Q35671234-E3E76AA5-BD6C-45E1-9E37-96DAB59253F9 Q35683636-8D93DAF1-B8FF-459C-9A1F-15A5D7572252 Q35811457-E73E0AC9-56CA-4D2F-9373-408E816C4452 Q36091813-35708AED-8D4E-460C-A64F-C09411A35C23 Q36230448-3F49E195-433B-4471-8022-98FFF5CD6FF4 Q36254216-C9CAA2D7-AF0D-4287-9C89-64ABE7CBEEE9 Q36354235-D2D9C616-BC87-4974-A09D-182217203F50 Q36452209-FA576EA8-4900-414C-AE3A-FC0E09CD2112 Q36458661-F6C1703C-7E80-483F-948A-5171D84CAB7F Q36469716-C8E64FCE-867E-49E6-B494-795BB5C916EF Q36691896-2F36DA1E-03A6-43B4-9922-41A5E38AC0E2 Q36780754-7D93307D-958C-49D7-9F82-CD2996F8172E Q36931690-6409FED1-BB0D-48D8-ABB1-0BB864828827 Q37048438-FBFBEAAB-61F6-4493-A447-F4784E3C09D1 Q37053186-E587BC33-EC23-45D7-B81F-C5AC2FF589D3 Q37061110-7E882DD9-0C5A-4AD2-BA45-51211707461F Q37107309-3615B098-8466-4504-823A-93D5D3FA2156

P2860

Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome

http://www.wikidata.org/entity/Q28266821

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Increased fibroblast growth fa ...... late with poor patient outcome

@ast

Increased fibroblast growth fa ...... late with poor patient outcome

@en

Increased fibroblast growth fa ...... late with poor patient outcome

@nl

type

label

Increased fibroblast growth fa ...... late with poor patient outcome

@ast

Increased fibroblast growth fa ...... late with poor patient outcome

@en

Increased fibroblast growth fa ...... late with poor patient outcome

@nl

prefLabel

Increased fibroblast growth fa ...... late with poor patient outcome

@ast

Increased fibroblast growth fa ...... late with poor patient outcome

@en

Increased fibroblast growth fa ...... late with poor patient outcome

@nl

P1433

Q28266821-C43FA720-6FEA-4CCF-80F3-395FF38A18D3

P1476

Q28266821-D866EE1F-388F-43B0-9412-B3A5A4E39CC4

P2093

Q28266821-1B91F609-5DFA-4A1F-B7A5-FDBB8D1A1AF4

Q28266821-2C406CAA-7E88-48D4-AD24-8EF5816F963A

Q28266821-2EC10859-58C6-4253-BAA4-81CB59198F0C

Q28266821-3724446C-78B4-4E65-BDA7-6DF070C71B96

Q28266821-440CDB56-7DDB-4B85-B02B-2CFE92AB346E

Q28266821-5D0F78C9-BD09-4C8E-B461-96075CAB450D

Q28266821-6DF30D0F-B012-4792-A474-03BCF96B9D7E

Q28266821-7151EB94-A36A-4415-9E6D-67D5E585F734

Q28266821-87F4AE70-83AD-496F-BDCB-DCF1D2A637D1

Q28266821-A1620F45-EF67-488A-BF51-FD3F56D2DD9D

P304

Q28266821-1E160BF5-425B-4BFF-9A93-2A4DF530A1B0

P31

Q28266821-86E7AF10-7417-4F1D-BD87-789CD6B96113

P3181

Q28266821-F5C5ECE7-51B7-4F19-AA6B-C9D3702EAF67

P356

Q28266821-6AD3B4B4-B844-4BA0-AEFF-B1F5A017D564

P407

Q28266821-AF87463B-B0D3-4C27-970B-A8E956395F88

P433

Q28266821-B5B8E257-A64A-4281-8AAA-89F88C8884DB

P478

Q28266821-30636211-3891-4897-A1AD-72742AA4A793

P50

Q28266821-E265B8F0-384A-4523-A940-5E4226788333

P577

Q28266821-A2EDA4CD-8EB3-49C9-96C9-ED17684B4714

P5875

Q28266821-8C58F6C1-4BF7-40A1-9A9A-D6350D44375D

P698

Q28266821-51BBEE97-2731-4D5D-8108-926CFEDB645D

P921

Q28266821-87E1D218-316F-4825-B527-8E3A64B0B3B5

P3181

P356

0008-5472.CAN-06-0418

P1433

Cancer Research

P1476

Increased fibroblast growth fa ...... late with poor patient outcome

@en

P2093

Benjamin A Savitch

http://www.w3.org/2001/XMLSchema#string

Christopher A Lipinski

http://www.w3.org/2001/XMLSchema#string

Galen Hostetter

http://www.w3.org/2001/XMLSchema#string

Heather E Cunliffe

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Winkles

http://www.w3.org/2001/XMLSchema#string

Jennifer S Michaelson

http://www.w3.org/2001/XMLSchema#string

Jessica L Rennert

http://www.w3.org/2001/XMLSchema#string

Joseph C Loftus

http://www.w3.org/2001/XMLSchema#string

Linda C Burkly

http://www.w3.org/2001/XMLSchema#string

Luigi Mariani

http://www.w3.org/2001/XMLSchema#string

P304

9535-9542

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4841750

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/0008-5472.CAN-06-0418

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Dominique B. Hoelzinger

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6775691

http://www.w3.org/2001/XMLSchema#string

P698

17018610

http://www.w3.org/2001/XMLSchema#string

P921